GB1151168A - Stabilised Penicillins - Google Patents
Stabilised PenicillinsInfo
- Publication number
- GB1151168A GB1151168A GB4547067A GB4547067A GB1151168A GB 1151168 A GB1151168 A GB 1151168A GB 4547067 A GB4547067 A GB 4547067A GB 4547067 A GB4547067 A GB 4547067A GB 1151168 A GB1151168 A GB 1151168A
- Authority
- GB
- United Kingdom
- Prior art keywords
- crystals
- sodium formaldehyde
- formaldehyde sulphoxylate
- polyvinylpyrrolidone
- penicillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Abstract
1,151,168. Stabilised penicillin compositions. AMERICAN HOME PRODUCTS CORP. 5 Oct., 1967 [16 Dec., 1966], No. 45470/67. Heading A5B. A stabilized therapeutic composition for parenteral administration comprises crystals having a particle size of 5-150 microns of benzathine penicillin G (N,N'-dibenzylethylenediamine dipenicillin) in an aqueous suspending medium which includes a wetting agent for the crystals, polyvinylpyrrolidone, and sodium formaldehyde sulphoxylate, the polyvinylpyrrolidone being present in an amount equal for at least ten times the weight of the sodium formaldehyde sulphoxylate and the sodium formaldehyde sulphoxylate being present as 0.05 to 0.5% on a weight to volume basis of the total composition. The benzathine penicillin G crystals may be coated with a coating composition comprising a wetting agent, e.g. a mixture of polyoxyethylene sorbitan monolaurate and stearyl alcohol. The compositions may also contain additional suspending agents, emulsifiers, surface active agents, anti-foaming agents, buffers and/or preservatives. -
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60218866A | 1966-12-16 | 1966-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1151168A true GB1151168A (en) | 1969-05-07 |
Family
ID=24410336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4547067A Expired GB1151168A (en) | 1966-12-16 | 1967-10-05 | Stabilised Penicillins |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE707750A (en) |
DE (1) | DE1617311A1 (en) |
FR (1) | FR1583411A (en) |
GB (1) | GB1151168A (en) |
IL (1) | IL28680A (en) |
NL (1) | NL6717120A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7618394B2 (en) | 1993-04-08 | 2009-11-17 | Powderject Research Limited | Needleless syringe using supersonic gas flow for particle delivery |
WO2016135075A1 (en) | 2015-02-23 | 2016-09-01 | Sandoz Ag | Penicillin retard composition for intramuscular injection |
-
1967
- 1967-09-25 IL IL2868067A patent/IL28680A/en unknown
- 1967-10-05 GB GB4547067A patent/GB1151168A/en not_active Expired
- 1967-12-08 BE BE707750D patent/BE707750A/xx unknown
- 1967-12-15 FR FR1583411D patent/FR1583411A/fr not_active Expired
- 1967-12-15 NL NL6717120A patent/NL6717120A/xx unknown
- 1967-12-18 DE DE19671617311 patent/DE1617311A1/de active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7618394B2 (en) | 1993-04-08 | 2009-11-17 | Powderject Research Limited | Needleless syringe using supersonic gas flow for particle delivery |
US7942846B2 (en) * | 1993-04-08 | 2011-05-17 | Powderject Research Limited | Needleless syringe using supersonic gas flow for particle delivery |
WO2016135075A1 (en) | 2015-02-23 | 2016-09-01 | Sandoz Ag | Penicillin retard composition for intramuscular injection |
US10159661B2 (en) | 2015-02-23 | 2018-12-25 | Sandoz Ag | Penicillin retard composition for intramuscular injection |
Also Published As
Publication number | Publication date |
---|---|
NL6717120A (en) | 1968-06-17 |
DE1617311A1 (en) | 1971-02-18 |
BE707750A (en) | 1968-04-16 |
IL28680A (en) | 1971-12-29 |
FR1583411A (en) | 1969-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1430634A (en) | Fibres of regenerated cellulose and polyacrylic acid salt of alkali-metals | |
ES468301A1 (en) | Instillation composition | |
GB1151168A (en) | Stabilised Penicillins | |
GB1532993A (en) | Injectable antibiotic compositions | |
ES8702137A1 (en) | Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance. | |
IE33861L (en) | Water-dispersible ampicillin preparations | |
GB1158167A (en) | Coated Asbestos-Cement Products | |
US2864844A (en) | Stabilized thimerosal | |
IE36916L (en) | Triazoloquinoline derivatives; pesticides | |
GB1468815A (en) | Pharmaceutical compositions | |
FR2070173A1 (en) | Stabilized aqs pyrocatecholamine prepns | |
IE33230B1 (en) | Anti-haemorrhoidally active preparations for local or rectal administration | |
IE34609B1 (en) | Antineoplastic therapeutic compositions | |
GB1137591A (en) | Medicine for the treatment of infections and allergies by nasal administration | |
IE781283L (en) | Sulphonamide-containing pharmaceutical composition | |
IE34226B1 (en) | Alpha-aminobenzyl penicillins | |
GB1272340A (en) | Derivatives of neriifolin | |
IL39889A0 (en) | Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof | |
GB1247929A (en) | Pesticides containing benzoyl cyanides | |
GB1223629A (en) | Anti-offset powder and method | |
GB1233150A (en) | ||
GB1422996A (en) | Polyamide resin compositions | |
Gallicchio | Lithium enhanced granulopoiesis and megakaryocytopoiesis in vitro: Potentiation with agents that accelerate sodium transport. | |
GB1395772A (en) | 1-aryl-3h-1,4-benzodiazepin-2,5-1h,4h-diones | |
CA931953A (en) | 2,(2',6'-dichlorophenyl)1,3-thiazine-4-one, methods of producing the said substance and preparations containing it as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |